PFAFFIKON, Switzerland, May 21, 2010 /PRNewswire/ —
– Europe’s Leading Stem Cell
Bank Launches Innovative Service for Liposuction Market
Cryo-Save today announced the European introduction of Cryo-Lip,
a new product that allows the collection, processing and storage of
a rich mixture of adult stem cells from liposuction aspirate (fatty
tissue that is normally discarded). A novel cryopreservation
process for fatty tissue has been developed and submitted as an
international patent by Cryo-Save.
Adult Stem Cells
The primary roles of adult stem cells are to maintain and repair
the tissue in which they are found. There are two main types:
Hematopoietic Stem Cells (HSCs), forming all blood cells and
Mesenchymal Stem Cells (MSCs), able to differentiate into multiple
cell types such as bone, fat, muscle and cartilage.
Fat or adipose tissue is an ideal source of adult stem cells:
– It is very rich in MSCs, for example a 500 times higher
concentration than in bone marrow
– It is readily available; the 50ml needed for Cryo-Lip can easily be
obtained from a liposuction
– It is autologous, adult tissue, and hence no ethical or
immunological issues
– It is normally discarded anyway
Clinical Applications
The use of Adipose-derived Stem Cells (ASCs) promises much as
testified by the exponential increase in both peer-reviewed medical
publications and ongoing clinical trials.
Professor Marco Gasparotti, an
eminent Plastic and Reconstructive Surgeon from Rome and the pioneer of the superficial
lipos
‘/>”/>
![An illustration showing the Edwards Lifesciences Sapien M3 transcatheter mitral valve replacement (TMVR) system's valve being placed in the heart. [Image courtesy of Edwards Lifesciences]](https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2025/04/Edwards-Lifesciences-Sapien-M3-TMVR-valve-delivery-268x170.jpg)